Rockwell Medical (NASDAQ:RMTI) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a report issued on Saturday.
Separately, Zacks Investment Research lowered Rockwell Medical from a “hold” rating to a “sell” rating in a research report on Thursday.
Shares of Rockwell Medical (NASDAQ:RMTI) traded up $0.23 during mid-day trading on Friday, reaching $6.10. The company had a trading volume of 426,500 shares, compared to its average volume of 357,050. The firm has a market capitalization of $315.74, a price-to-earnings ratio of -14.19 and a beta of 2.02. Rockwell Medical has a 1 year low of $5.06 and a 1 year high of $8.98.
Hedge funds have recently made changes to their positions in the stock. Raymond James Financial Services Advisors Inc. acquired a new position in shares of Rockwell Medical during the 3rd quarter worth about $107,000. PNC Financial Services Group Inc. grew its position in shares of Rockwell Medical by 1,725.7% during the 2nd quarter. PNC Financial Services Group Inc. now owns 15,245 shares of the company’s stock worth $121,000 after buying an additional 14,410 shares during the period. UBS Asset Management Americas Inc. grew its position in shares of Rockwell Medical by 38.3% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 19,843 shares of the company’s stock worth $157,000 after buying an additional 5,500 shares during the period. Private Advisor Group LLC acquired a new position in shares of Rockwell Medical during the 2nd quarter worth about $182,000. Finally, National Asset Management Inc. acquired a new position in shares of Rockwell Medical during the 2nd quarter worth about $203,000. Hedge funds and other institutional investors own 21.26% of the company’s stock.
About Rockwell Medical
Rockwell Medical, Inc (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process.
What are top analysts saying about Rockwell Medical? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Rockwell Medical and related companies.